Alpha 2.0
Login Register
» Articles » PMID: 32646492

The Pediatric Supratentorial MYCN-amplified High-grade Gliomas Methylation Class Presents the Same Radiological, Histopathological and Molecular Features As Their Pontine Counterparts

Overview
Journal Acta Neuropathol Commun
Publisher Biomed Central
Specialty Neurology
Date 2020 Jul 11
PMID 32646492
Citations 18
Authors
A Tauziede-Espariat
M-A Debily
D Castel
J Grill
S Puget
A Roux
R Saffroy
M Pages
A Gareton
F Chretien
E Lechapt
V Dangouloff-Ros
N Boddaert
P Varlet
Affiliations
Soon will be listed here.
Citing Articles

Pediatric high-grade gliomas with concomitant RB1 and SETD2 alterations and Li-Fraumeni syndrome.

Tauziede-Espariat A, Simbozel M, Sievers P, Dangouloff-Ros V, Guida L, Blauwblomme T Acta Neuropathol Commun. 2025; 13(1):8.

PMID: 39815333 PMC: 11737212. DOI: 10.1186/s40478-024-01885-x.

Emerging and Biological Concepts in Pediatric High-Grade Gliomas.

Yoel A, Adjumain S, Liang Y, Daniel P, Firestein R, Tsui V Cells. 2024; 13(17.

PMID: 39273062 PMC: 11394548. DOI: 10.3390/cells13171492.

Cortically Based Brain Tumors in Children: A Decision-Tree Approach in the Radiology Reading Room.

Rameh V, Lobel U, DArco F, Bhatia A, Mankad K, Poussaint T AJNR Am J Neuroradiol. 2024; 46(1):11-23.

PMID: 39181692 PMC: 11735440. DOI: 10.3174/ajnr.A8477.

Molecular and Pathological Features of Paediatric High-Grade Gliomas.

Blasco-Santana L, Colmenero I Int J Mol Sci. 2024; 25(15).

PMID: 39126064 PMC: 11312892. DOI: 10.3390/ijms25158498.

Pediatric CNS tumors and 2021 WHO classification: what do oncologists need from pathologists?.

dAmati A, Bargiacchi L, Rossi S, Carai A, Bertero L, Barresi V Front Mol Neurosci. 2024; 17:1268038.

PMID: 38544524 PMC: 10966132. DOI: 10.3389/fnmol.2024.1268038.

References
1.
Wang L, Li Z, Zhang M, Piao Y, Chen L, Liang H . H3 K27M-mutant diffuse midline gliomas in different anatomical locations. Hum Pathol. 2018; 78:89-96. DOI: 10.1016/j.humpath.2018.04.015. View
2.
Mackay A, Burford A, Molinari V, Jones D, Izquierdo E, Brouwer-Visser J . Molecular, Pathological, Radiological, and Immune Profiling of Non-brainstem Pediatric High-Grade Glioma from the HERBY Phase II Randomized Trial. Cancer Cell. 2018; 33(5):829-842.e5. PMC: 5956280. DOI: 10.1016/j.ccell.2018.04.004. View
3.
Broniscer A, Hwang S, Chamdine O, Lin T, Pounds S, Onar-Thomas A . Bithalamic gliomas may be molecularly distinct from their unilateral high-grade counterparts. Brain Pathol. 2016; 28(1):112-120. PMC: 5489374. DOI: 10.1111/bpa.12484. View
4.
Sturm D, Witt H, Hovestadt V, Khuong-Quang D, Jones D, Konermann C . Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. Cancer Cell. 2012; 22(4):425-37. DOI: 10.1016/j.ccr.2012.08.024. View
5.
Korshunov A, Schrimpf D, Ryzhova M, Sturm D, Chavez L, Hovestadt V . H3-/IDH-wild type pediatric glioblastoma is comprised of molecularly and prognostically distinct subtypes with associated oncogenic drivers. Acta Neuropathol. 2017; 134(3):507-516. DOI: 10.1007/s00401-017-1710-1. View